Concepedia
Statistics
Publications
34
Citations
1.2K
H-Index
23
Active since
1982
Affiliations
University of Utah(Current)
Children's Hospital of Philadelphia
Boston Children's Hospital
Primary Children's Hospital
Harvard University
Thomas A. Miller is an author at University of Utah specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryPediatricsPharmacotherapyChild DevelopmentMedicinal ChemistryBiologyChromatinEntomology
Publications per year
1982–2023
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2)
David J. Witter, Paul E. Harrington, Kevin J. Wilson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 94 citations · Full text
Biaryl Selective Hdac1, Molecular Pharmacology, Medicinal Chemistry +7
De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapes
W. Scott Watkins, Edgar J. Hernández, Sergiusz Wesołowski et al. · Nature Communications · 2019 · 89 citations · Full text
Histone Deacetylase Inhibitors: Development as Cancer Therapy
Paul A. Marks, Victoria M. Richon, Wm. Kevin Kelly et al. · Novartis Foundation symposium · 2004 · 85 citations
Histone Modifications, Hdac Inhibitors, Chemoprevention Strategy +19
Creating the Exceptional Patient Experience in One Academic Health System
Vivian S. Lee, Thomas A. Miller, Chrissy Daniels et al. · Academic Medicine · 2015 · 54 citations · Full text
Family Medicine, Quality Of Life, Patient Satisfaction Metrics +17
Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities
Andrea Newbold, Geoffrey M. Matthews, Michael Bots et al. · Molecular Cancer Therapeutics · 2013 · 46 citations
Histone Modifications, Chemoprevention Strategy, Epigenetic Change +20
1–5 of 34